PULMONARY REHABILITATION IN COPD PATIENTS. OBSERVATIONAL STUDY
|
|
- Lionel Wood
- 5 years ago
- Views:
Transcription
1 Med. Surg. J. Rev. Med. Chir. Soc. Med. Nat., Iaşi 2018 vol. 122, no. 3 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS PULMONARY REHABILITATION IN COPD PATIENTS. OBSERVATIONAL STUDY Mara Bălteanu 1, C. Kamal 2, Diana Kamal 3, Paraschiva Postolache 4,5*, Rodica Trăistaru 2 1. Marius Nasta National Institute of Pneumophtysiology, Bucharest University of Medicine and Pharmacy Craiova 2. Faculty of Medicine 3. Elga Polyclinic, Craiova Grigore T. Popa University of Medicine and Pharmacy Iasi Faculty of Medicine 4. Department of Medical Specialties (I) 5. Rehabilitation Clinical Hospital, Iasi * Corresponding author. par.postolache@umfiasi.ro PULMONARY REHABILITATION IN COPD PATIENTS-OBSERVATIONAL STUDY (Abstract): The aim was to analyze the effects of an 8-week pulmonary rehabilitation (PR) program on quality of life (QoL), physical performance (6MWD value - six-minute walk test) and pulmonary function in patients with mild and moderate COPD. Material and methods: 23 subjects with COPD with FEV1 50% were assigned to a clinic treatment group (n=12) or a home exercise group (n=11). Subjects in the first group received supervised exercise program over a 6-week period after 2 weeks inpatient PR program. Subjects in the second group received the same exercise program initially in hospital, followed by 6 weeks of home exercises, reinforced by a clinic visit at 2 weeks. Measured outcomes were the 6MWD, the generic QoL scale St. George s Respiratory Questionnaire Disease (SCRQ) and statist i- cal analysis by ANOVA test. Results: Both groups showed clinically and statistically significant improvements in 6MWD and SCRQ scores at 8 weeks; improvements were still evident in both groups at 3 months. By 8 weeks, SGRQ scores had improved in both groups with 28% and 24%; 6 MWD had improved with 13% and 5%, and important differences were observed in the mean changes of 6MWD: m in the first group, 17.7 m in the second group. At 3 months, the results of both groups were substantially and about equally i m- proved over baseline measurements. Conclusions: Subjects in the first group were more satisfied with the overall outcome of their rehabilitation treatment compared with subjects in the second group. Keywords: PULMONARY REHABILITATION, COPD, QUALITY OF LIFE, PHYSICAL PERFORMANCE, PULMONARY FUNCTION. Chronic Obstructive Pulmonary Disease (COPD) is a common preventable and treatable disease, characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases (1). COPD patients must face limitations in daily activities and reduced quality of life (QoL) caused by dyspnea, airflow limitation, skeletal muscle dysfunction and comorbidities (1, 2, 3, 4, 5). The major 474
2 Pulmonary rehabilitation in COPD patients. Observational study goals of stable COPD management are to reduce symptoms, increase participation in daily living activities and improve healthrelated quality of life (HRQoL) (1, 2, 3, 6). The pharmacological treatment of COPD is main target is to reduce the degree of airflow limitation and there is evidence that FEV1 has a relatively poor correlation with symptoms, HRQoL and daily functioning (7, 8, 9). American Thoracic Society (ATS) and European Respiratory Society (ERS) recommendations for the management of COPD are to use of pulmonary rehabilitation programs (PRPs) for all groups of risk of the illness (A, B, C, D), especially selfmanagement techniques to improve exercise tolerance and HRQoL, and to reduce symptoms like dyspnea and fatigue (1, 2, 10, 11). PRPs have been shown not only to improve exercise capacity and health status and to reduce dyspnea and but also to diminish the use of healthcare resources (2, 6, 12-18). We carried out a comparative study single blind to analyze the effects of an 8 weeks rehabilitation program on dyspnea, HRQoL, physical performance and pulmonary function in patients with mild and moderate COPD (19, 20). The aim of the study was to evaluate functional capacity and health status at 8 weeks of physical treatment and at 3 months after conclusion of PRP in patients regularly followed in respiratory health services. MATERIAL AND METHODS All patients with a confirmed diagnosis of COPD with FEV1>50% admitted to a PRP at Physical Medicine and Rehabilitation Department, Hospital No. 2, Craiova, between January 2018 and May 2018 were recruited (tab. I). The diagnosis of COPD was made according to GOLD definition and classification (1, 7, 9). All patients received pharmaceutical treatment according with COPD GOLD stage. The respiratory specialist oversaw confirming the diagnoses, treatment and verifying exclusion criteria. PRP of mild/moderate COPD patients included: the patient selection and initial evaluation, the goal developing, the ensuring the smooth running of the program, the evaluation of patient outcomes, the performing of long/term follow-up. On admission, patients were excluded from this study if they had a diagnosis of other pulmonary disease, with unstable cardiac conditions, neuromotor limitation or COPD patients with a recent exacerbation (in the preceding 4 weeks). TABLE I The main characteristics of the study patients Study group 1 (G1) Study group 2 (G2) No of patients Gender 10 M / 2 W 8 M / 3 W Mean age 46 (±8) years old 48 (±7) years old Own place 7 V, 5 T 6 V, 5 T Smokers Tobacco index 23 PA 26 PA (mean) Onset of COPD 3.2 years 4.4 years (mean) FEV 1 initial 65.5 % % W = women, M = men, V = village, T = town Study design The study design as a flow diagram: pre-to-post comparisons were made in those patients (fig. 1). 475
3 Mara Bălteanu et al. Fig. 1. A flow diagram of study design The patients with mild and moderate COPD were begun 8 weeks of PRP in the hospital. Sessions were supervised by a rehabilitation therapist. According with patient s preference and to the probability that patient maintain the exercise at home, patient was randomized in two study groups. Both groups started PRP in hospital for 2 weeks. After, the study group (G1) - received supervised exercise in hospital (outpatient PRP). The second group of patients (G2) received the same exercise program initially - in hospital, followed by 6 weeks of PRP at home residence, reinforced by a clinic visit at 2 weeks. We performed a complete history, physical examination, chest radiography, laboratory and pulmonary function data. The studied parameters were: dyspnea - using Medical Research Council (MRC) scale (16); pulmonary lung function: FEV1 and FEV1/FVC % using a spirometer (Vitalograph) connected to a computer, for a data analysis (1,8,9); exercise capacity: six-minute walking distance (6 MWD) according to the ATS Guidelines (17); 476
4 Pulmonary rehabilitation in COPD patients. Observational study QoL using St. George s Respiratory Questionnaire Disease (SGRQ) - a standardized, self-administered questionnaire for measuring impaired health and perceived HRQL in airways disease (21, 22). All evaluations were performed by the pulmonary physician, without knowing the location of the PRP. Patients were able to perform the inpatient (2 weeks) and outpatient (6 weeks) RPPs. The size of group at any session was limited to 5 patients. The rehabilitation methods we used were: monitoring pharmacotherapy, education 15 minutes daily sessions (breathing retraining, energy conservation, nutritional and medication education, smoking cessation, teaching the patients how to cope with feelings of dyspnea), physical training and educational and psychological management. The second part was devoted to physical training, preceded by Jacobson s technique, for twice-daily, 3 days a week, for eight weeks, 30-minute sessions, at 75-80% of the load achieved on the incremental pre-exercise test carried out at enrollment, and consisted of: respiratory muscle training - inspiring against a closed glottis, pursed lips breathing, expiratory abdominal augmentation and synchronization of thoracic and abdominal movements; modified proprioceptive neuromuscular training (four periods with 5 minutes of repetitive large muscle dynamic exercise separated by 1 minute with mild exercise), including stretching as part of the warm-up period and of the cool-down, respectively; complete lower extremity aerobic training on a cycle ergometer (Aerobic 2100) / the morning session; training workload was assessed daily in the inpatients and weekly in the outpatients. After 2 weeks of inpatients PRP, the patient of G1 continued physical therapy in hospital 3 days a week like outpatient PRP. The patient of G2 continued PRP at home. The study was approved by the Ethics Committee of the University of Medicine and Pharmacy Craiova and was carried out in concordance with the World Medical Association Declaration of Helsinki (2000). We have obtained informed consent from our patients for the treatment and for their medical data to be used in a study. Statistical analysis Data are presented as mean ± standard deviation for continuous variable and percentages for categorical variables. The difference between means was determined using Student s t-test. Differences parameter values between groups were tested by ANOVA test. A p-value <0.05 was considered statistically significant. The statistical analysis was performed using SPSS 8.0 for Windows; SPSS Inc., Chicago, IL, SUA and applied according to the current methodology. RESULTS After 8 weeks of PR all subjects reduce dyspnea - we obtained a fall in breathlessness mean score, had a significant, albeit small, improvement in mean FEV1, extended exercise endurance (6 MWD increased significantly), enhanced HRQoL (we considered 4 points as minimal clinically important difference as stated by Paul Jones), reduced use of pharmacological agents (tab. II). For G1 we did not identify any significant difference between the mean values for FEV1 measured at three points (p ANOVA = 0.759> 0.050). Spirometry showed at all patients, especially in younger, small increases in FEV1 after 8-week 477
5 Mara Bălteanu et al. inpatient PR. At 3-month FEV1 increased at %. For G2 we did not identify any significant difference between the mean FEV1values at three points (p ANO- VA=0,913>0,050); spirometry showed small increases in FEV1 after 8-week PR (FEV1=69.05%) compared to initial (FEV1=68.8%). For FEV1 we have ident i- fied no statistically significant difference between G1 and G2 (tab. II). Parameter Study group TABLE II Results of PRP in the two-study group Baseline After 8-week rehabilitation After 3 months Mean Std.dev. CI.95% p Mean Std.dev. CI.95% p Mean Std.dev. CI.95% p FEV1 % predicted G1= G2= MRC scale score G1= G2= Well-being (SGRQ total score) G1= G2= MWD (m) G1= G2= For G1, we obtained a fall in breathlessness mean score (MCR scale) with 45% of the initial score after 8 weeks; we identified a significant difference at the boundary between the MRC mean values to three times (p ANOVA = <0.050). In the G2, MCR mean score decreased with 38% after 8 weeks, but at 3 months was decreased only with 12%, without significant difference between the mean values (p ANOVA = 0.553> 0.050). We have identified a statistically significant difference only for the initial investigation (p = Student <0.050), between G1 and G2. For G1, we identified a significant difference between the mean values measured for SGRQ at three points (p ANOVA = 0.007<0.050). At the end of PRP there was an improvement in health status in both groups. At 8 weeks in G1, mean SGRQ score increased with 28% and with 24% in 3 months after PRP compared by baseline (tab. II). On the contrary, in G2, if at 8 weeks SGRQ score was better that before PRP with 26%, there were changes in total SGRQ score, with a tendency to get worst at 3 months after PRP, when the mean SGRQ score was increased only with 7% 478
6 Pulmonary rehabilitation in COPD patients. Observational study compared by baseline (tab. II). Comparing the results between G1 and G2 we have not identified at any of the three points, any statistically significant difference. After PRP, in the G1, mean 6MWD was clinically and statistically significant increased at 8 weeks (+13%) (tab. II). We identified a significant difference between the mean 6MWD values at three points for G1 (p ANOVA = 0.001<0.050). In G2, mean 6MWD was increased at 8 weeks (+17.7m =5%) compared with initial values. After completing PRP inpatient, 6MWD was increased only with 2% compared with baseline (tab. II). For G2 did not identify any significant difference at three points (p ANOVA = 0.840> 0.050). Comparing the results between the two groups we have not identified at baseline, a statistically significant difference, but the investigation of the second and the final difference between the two groups became statistically significant difference (the end p Student = 0.003, the intermediate p Student = 0.012). Although all parameters studied had a favorable evolution, when we performed linear regression equation for the mean initial values and intermediary, respectively final values of the studied parameters, we found that initial value are predictive for both intermediary and final values only in G1 (fig. 2, 3, 4). Fig. 2. The frequency graphs of linear regression equations for MRC Fig. 3. The frequency graphs of linear regression equations for SGRQ 479
7 Mara Bălteanu et al. Fig. 4. The frequency graphs of linear regression equations for 6MWD DISCUSSION The benefits of the PRP in the management of patients with chronic respiratory disease already known and well-established (1, 2, 3, 6-12, 14, 15), were also observed in this study. The studies published so far in the literature show the positive effects rehabilitation has in patients with moderate to severe (23, 24), very severe COPD (25) or comorbidities (26). The present study highlights the benefits of PR in patients diagnosed with COPD with FEV1> 50% without comorbidities, rehabilitation initially performed under hospital conditions, then at home. In both groups, after PRP, patients showed improvement in health status and but not in functional capacity. Studied patients have carried out a PRP during two weeks in hospital treatment, followed by six weeks at home (G2) or hospital (G1) GOLD appreciates the minimum duration of an effective PRP is at least 6 weeks, the effectiveness increases with increasing duration (1). Our program duration was greater than the minimum recommended two weeks of GOLD 2014 and the British Thoracic Society (6 weeks) (27). Compared with other studies (24, 25), the duration of the program is average, and there are programs for 4 weeks or three years (23), in moderate-severe COPD (24), and 26 weeks for patients with severe ventilatory dysfunction (25). Other studies evidenced that longer programs seem to enhance long-term effects (23, 28). Initiation of the program was carried out under hospital conditions, which is considered necessary given the fact that patients have never carried out such a program and requiring the careful monitoring of respiratory function during exercise. Subsequent completion (out-patient and home-training) was done to capture the effects of PR in the two situations. We mention that carrying home-training program was accepted in patients who did not have easy access to the out-patient services. In the literature we didn t find any studies we could refer to, the more often patients performing an outpatient PRP (24, 25, 29). The limited number of patients compared to other studies (25, 30, 31), is explained by the inclusion only patients with FEV1>50%, without comorbidities and poor adherence for this form of nonpharmacological treatment. We do not have an explanation for the poor adherence of G2 to the PRP, as both groups were similar in terms of baseline clinical and demo- 480
8 Pulmonary rehabilitation in COPD patients. Observational study graphic characteristics and similar PRP benefits in both groups (tab. I). Translation of the acquired skills to patient s lifestyle may be prevented by different barriers: lack of self-confident, cognitive impairment and behavioral issues, lack of motivation and the presence of physical barriers at home or in the community (25, 32). The G2 poor adherence to follow-up testing could be explained by the fact they were also less compliant to exercise. A possible explanation for the worst longterm results with patients that did cycling during PRP, could be the difficult maintaining this exercise regularly at home and consequently they became less active. We mention that most patients with COPD have a respiratory function with a severe or very severe reduction (FEV1 < 50%), highlighting the absence or ineffectiveness of programs for early detection of smoking-induced pathology or respiratory hazards. Most patients included in the study came from rural areas. Unlike other studies in which correlations are made between respiratory function parameters (29, 30, 31), in our study we followed the recovery program effects on pulmonary function, exercise capacity (6MWD), dyspnea (MRC) and quality of life (SGRQ) after 6 weeks of rehabilitation and three months after the end of the program. In our study we didn t set out to achieve a target intensity of 80% of peak work rate but strived that in the first 2 weeks of the rehabilitation program, patients would learn a correct respiratory pattern (4 stage), with physical effort during exhale. For FEV1 parameter we cannot appreciate an improvement percentage, given the irreversible character of the lesions and respiratory function degradation in COPD, regardless of the therapeutic method applied. 6MWD values were in the concordance with the literature (29, 31). The improvement of 6MWD after the rehabilitation was higher compared with other published results (29,31). This is because our patients perform daily physical exercises; most of them come from rural areas. Also, our patients were complaining to proprioceptive training. Like other literature data (33) our results confirmed that regular aerobic exercise is associated with minimal increase in overall health status and walking selfefficacy, expressed through 6 MWD, as well as a reducing progression of dyspnea, especially during activities of daily living effort. After 12 weeks the results of PR program are decreasing, similar another publication (34), perhaps due to limiting interest for constant and daily proprioception training. As limitations of this study we can consider the small number of patients, the short duration of follow-up phase, compared with other studies (35, 36) and lack of comorbidities. Poor adherence has a detrimental effect on morbidity, mortality and health care resources (37). In appropriate future, PRP in Romania should become a current medical option in all disabled patients, so the mentioned limits will be eliminated. CONCLUSIONS The results of the present study show that the proprioception is fundamental for sensory/motor control over thorax joint stability, so our proprioceptive neuromuscular training offers optimal control of respiratory movements and is essential in patients with COPD. Combining in-patient / out-patient or in- 481
9 Mara Bălteanu et al. patient / home-training is an optimal way in which the patient with COPD with FEV1>50% improve their exercise capacity and Qol. Based on the results of this study, there is a need for more research on this subject. We consider that chest stretching and adapted neuromuscular training represent two important educational needs of an individual COPD patient management. REFERENCES 1. ***GOLD 2017: Global Strategy for the Diagnosis, Management and Prevention of COPD Rochester CL, Vogiatzis I, Anne E, et al. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med 2015; 192(11): Celli BR, Decramer M, Wedzicha JA, et al. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2015; 191(7): e4-e Nemes RM, Duceac LD, Vasincu EG, Agop M, Postolache P. On the Implications of the Biological Systems Fractal Morpho-Functional Structure. U.P.B. Sci.Bull., Series A 2015; 77(4): Postolache P, Duceac LD, Vasincu EG, Agop M, Nemeş RM. Chaos and self-structuring behaviors in lung airways. U.P.B. Sci.Bull., Series A 2016; 78(1): Postolache P, Nemes RM, Croitoru A, Constantin B. The Role of Pulmonary Rehabilitation in Occupational COPD. JEPE 2015; 16(2): O Reilly J, Jones MM, Parnham J, et al. Guideline Development Group. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ 2010; 340: c Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: Qaseem A, Wilt T, et al. Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: Spruit MA, Singh SJ, Garvey C, et al. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med 2013; 188 (8): e13-e Nici L, Donner C, Wouters E, et al. American Thoraic Society/European Respiratory Society Statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: Effing T, Monninkhof EM, van der Valk PDea. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007; (4):CD Postolache P, Cozma CD, Cojocaru DC. Assessment of Nicotine Dependence in a Large Cohort of Smokers - Social and Medical Aspects. Rev of Res and Soc Interv 2013; 41: Traistaru R, Marcu R, Popescu R. Exercise performance in chronic bronchial asthmatic patients. J of Rehab Med 2008; 40(Suppl. 47): Murphy K, Casey D, Devane D, et al. A cluster randomized controlled trial evaluating the effectiveness of a structured pulmonary rehabilitation education programme for improving the health status of people with chronic obstructive pulmonary disease (COPD): The PRINCE Study Protocol. BMC Pulm Med 2011; 482
10 Pulmonary rehabilitation in COPD patients. Observational study 16. Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: ***ATS statement: guidelines for the six-minute walk test. Am J Crit Care Med 2002; 166: Postolache P, Cojocaru DC. Pulmonary rehabilitation-from guidelines to practice. Rev Med Chir Soc Med Nat, Iasi 2013; 117(2): Traistaru R, Popescu-Hagen M, Nitu M, Ardelean D, Postolache P. Pulmonary Rehabilitation and Quality of Life in Elderly Females with COPD. Chest 2014; 146(4): 541 A 20. Popescu-Hagen M, Traistaru R, Marica C, Rogoveanu O, Tanasescu M, Postolache P. An Eight Week Pulmonary Rehabilitation in COPD Patients: Observational Study. Chest 2014; 146(4): 541 A. 21. Jones P, Quirk F, Baveystock C. The St. George s Respiratory Questionnaire. Respir Med 1991; 85: Jones P, St. George s Respiratory Questionnaire: MCID. COPD 2005; 2: Stav D, Raz M, Spirer I. Three years of pulmonary rehabilitation: inhibit the decline in airflow obstruction, improves exercise endurance time, and body-mass index, in chronic obstructive pulmonary disease. BMC Pulm Med 2006; 9: Bianchi R, Gigliotti F, Romagnoli I, et al. Impact of a rehabilitation Program on Dyspnea Intensity and Quality in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2011; 81: Areias V, Ferreira D, Martins A, et al. Evolution of functional capacity and health status 2 years after a Pulmonary Rehabilitation Program. Rev Port Pneumol 2012; 18(5): Crisafulli E, Gorgone P, Vagaggini B, et al. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J 2010; 36: Bolton CE, BevanSmith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013; 68: ii1-ii Ståhl E, Lindberg A, Jansson S, et al. Health-related quality of life is related to COPD disease severity. Health and Quality of Life Outcomes 2005; 3: Rossi G, Florini F, Romagnoli M, et al. Length and Clinical Effectiveness of Pulmonary Rehabilitation in Outpatients with Chronic Airway Obstruction. CHEST 2005; 127: Pitta F, Takaki MY, Oliveira NH, et al. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Resp Med 2008, 102: Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009; 33: Fisher M, Abbink J, Rudolphus A, et al. Participation and drop-out in pulmonary rehabilitation qualitative analysis of the patient s perspective. Clin Rehabil 2007; 21: Heppner P, Morgan C, Ries A. Regular walking and long-term maintenance of outcomes after pulmonary rehabilitation. J Cardiopulm Rehabil 2006; 26: Spencer L, Alison J, McKeoug Z. Maintaining benefits following pulmonary rehabilitation: a randomized controlled trial. Eur Respir J 2010; 35: Brooks D, Krip B, Mangovski-Alzamora, Goldstein R. The effect of post rehabilitation programmes among individuals with chronic obstructive pulmonary disease. Eur Respir J 2002; 20: Weldam M, et al. Perceived quality of life in chronic obstructive pulmonary disease patients: a crosssectional study in primary care on the role of illness perceptions. BMC Family Practice 2014; 15: 140, Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluña JJ, van der Molen T, Adamek L, Banik N. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011; 105(1):
They Can t Bury You while You re Still Moving: Update on Pulmonary Rehabilitation
They Can t Bury You while You re Still Moving: Update on Pulmonary Rehabilitation Richard ZuWallack, MD Associate Chief, Pulmonary and Critical Care St. Francis Hospital, Hartford, CT Professor of Medicine
More informationPulmonary Rehabilitation in Chronic Lung Disease; Components and Organization. Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept.
Pulmonary Rehabilitation in Chronic Lung Disease; Components and Organization Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept. Plan Chronic Respiratory Disease Definition Factors Contributing
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP230 Section: Medical Benefit Policy Subject: Outpatient Pulmonary Rehabilitation I. Policy: Outpatient Pulmonary Rehabilitation II. Purpose/Objective: To provide
More informationIs there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life?
Is there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life? Summary of the evidence located: According to the NICE guideline on Chronic Obstructive Pulmonary Disease
More informationComparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification
ORIGINAL ARTICLE COPD Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification Paul W. Jones 1, Lukasz Adamek 2, Gilbert Nadeau 2 and Norbert Banik 3 Affiliations:
More informationPulmonary Rehabilitation in COPD-An Important Non-pharmacological Treatment
122 Review Article Pulmonary Rehabilitation in COPD-An Important Non-pharmacological Treatment Department of Adult Nursing, Maharajgunj Nursing Campus, Institute of Medicine, Tribhuvan University, Kathmandu,
More informationEvidence for early Pulmonary Rehabilitation following hospitalisation for exacerbation of COPD
Centre for Inflammation Research Evidence for early Pulmonary Rehabilitation following hospitalisation for exacerbation of COPD Pulmonary Rehabilitation Clinicians Day Roberto A. Rabinovich ELEGI/Colt
More informationPublished in: Archives of Physical Medicine and Rehabilitation
A comparison of twice-versus once-weekly supervision during pulmonary rehabilitation in chronic obstructive pulmonary disease. O'Neill, B., McKevitt, A. M., Rafferty, S., Bradley, J. M., Johnston, D.,
More informationOutpatient Pulmonary Rehabilitation
Outpatient Pulmonary Rehabilitation Policy Number: 8.03.05 Last Review: 7/2017 Origination: 7/1995 Next Review: 7/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for
More informationDouglas W. Mapel MD, MPH, Melissa Roberts PhD
Original Article Spirometry, the St. George s Respiratory Questionnaire, and other clinical measures as predictors of medical costs and COPD exacerbation events in a prospective cohort Douglas W. Mapel
More informationCARE OF THE ADULT COPD PATIENT
CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The
More informationHealth-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index
Chronic Respiratory Disease 2009; 6: 75 80 http://crd.sagepub.com ORIGINAL PAPER Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index
More informationLEARNING OBJECTIVES FOR COPD EDUCATORS
LEARNING OBJECTIVES FOR COPD EDUCATORS For further Information contact: INTERNATIONAL NETWORK FOR RESPIRATORY CARE 16851 Mount Wolfe Road Caledon, ON Canada L7E 3P6 Phone: 905 880-1092 Fax: 905 880-9733
More informationUpdate on Pulmonary Rehabilitation Programme. HA Convention Dr. Wong WY, Ida Haven of Hope Hospital 8 May 2018
Update on Pulmonary Rehabilitation Programme HA Convention Dr. Wong WY, Ida Haven of Hope Hospital 8 May 2018 Impacts of COPD to patients Increase dyspnoea Limitation of activity Decrease quality of life
More informationMEDICAL POLICY SUBJECT: PULMONARY REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation
MEDICAL POLICY PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationA Validation Study for the Korean Version of Chronic Obstructive Pulmonary Disease Assessment Test (CAT)
http://dx.doi.org/10.4046/trd.2013.74.6.256 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2013;74:256-263 CopyrightC2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights
More informationShort- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial
See Editorial, p 2 c Additional details are published online only at http:// thorax.bmj.com/content/vol65/ issue1 1 Department of Respiratory Medicine, Máxima Medical Centre, Veldhoven, The Netherlands;
More informationChronic Obstructive Pulmonary Disease (COPD) is a systematic disease with
Chronic Obstructive Pulmonary Disease (COPD) is a systematic disease with considerable impact on several dimensions of daily life. Those that suffer from COPD can be submitted to rehabilitation programmes.
More informationKey words: COPD, prediction, pulmonary rehabilitation, response.
ERJ Express. Published on February 15, 2006 as doi: 10.1183/09031936.06.00130605 1 Predictors of Success and Failure in Pulmonary Rehabilitation Short title: Success and Failure in pulmonary rehabilitation
More informationA comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD
RESPIRATORY MEDICINE (2001) 95, 71 77 doi:10.1053/rmed.2000.0976, available online at http://www.idealibrary.com on A comparison of three disease-specific and two generic health-status measures to evaluate
More information호흡재활치료 울산의대서울아산병원 호흡기내과 이상도
호흡재활치료 울산의대서울아산병원 호흡기내과 이상도 Systemic (Extrapulmonary) effects in COPD Skeletal muscle dysfunction Osteoporosis Weight loss Sexual dysfunction Cardiovascular diseases (Gross et al., Curr Opin Pulm Med 2001;7:84)
More informationDifferential diagnosis
Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between
More informationDr B. Egger Service de Pneumologie Hôpital de Rolle
Dr B. Egger Service de Pneumologie Hôpital de Rolle Planning COPD/rehabilitation introduction COPD rehabilitation programs : Benefits Components/Modalities COPD and congestive heart failure COPD and ischemic
More informationRoflumilast (Daxas) for chronic obstructive pulmonary disease
Roflumilast (Daxas) for chronic obstructive pulmonary disease August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationThe COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study
1 St George s Hospital NHS Trust, London, UK 2 Guy s and St Thomas Foundation NHS Trust, London, UK 3 Greenwich Primary Care Trust, London, UK 4 Croydon Primary Care Trust, London, UK 5 The NIHR Respiratory
More informationรศ. นพ. ว ชรา บ ญสว สด M.D., Ph.D. ภาคว ชาอาย รศาสตร คณะแพทยศาสตร มหาว ทยาล ยขอนแก น
รศ. นพ. ว ชรา บ ญสว สด M.D., Ph.D. ภาคว ชาอาย รศาสตร คณะแพทยศาสตร มหาว ทยาล ยขอนแก น COPD Guideline Changing concept in COPD management Evidences that we can offer COPD patients better life COPD Guidelines
More informationexacerbation has greater impact on functional status than frequency of exacerbation episodes.
Original Article Singapore Med J 2011, 52(12) 894 Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Bu X N, Yang T, Thompson M A, Hutchinson A F, Irving
More informationThe Importance of Pulmonary Rehabilitation
November 21, 2017 The Importance of Pulmonary Rehabilitation Presenter: George Pyrgos, MD 1 The importance of Pulmonary Rehabilitation George Pyrgos, MD Medical Director of the Angelos Lung Center at Medstar
More informationCare Bundle. Adult patients with COPD
Care Bundle Adult patients with COPD Version 2 July 2014 What is a care bundle? A care bundle is a set of interventions that, when used together, significantly improve patient outcomes. The measures chosen
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationValidation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease
Pothirat et al. BMC Pulmonary Medicine 2014, 14:193 RESEARCH ARTICLE Open Access Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease Chaicharn
More informationCLINICAL MEDICAL POLICY
CLINICAL MEDICAL POLICY Policy Name: Pulmonary Rehabilitation Policy Number: MP-058-MD-DE Responsible Department(s): Medical Management Provider Notice Date: 10/01/2017 Original Effective Date: 11/01/2017
More informationThe distribution of COPD in UK general practice using the new GOLD classification
ERJ Express. Published on October 31, 2013 as doi: 10.1183/09031936.00065013 The distribution of COPD in UK general practice using the new GOLD classification John Haughney 1, Kevin Gruffydd-Jones 2, June
More informationPatient reported outcomes in respiratory diseases; How to assess clinical success in COPD
Patient reported outcomes in respiratory diseases; How to assess clinical success in COPD Thys van der Molen, University of Groningen, Department of General Practice, The Netherlands Mr Valette Smoking
More informationMULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient
Clinical Guideline Ver. 2.0 MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient Target Audience: The target audience for this clinical guideline is all MHS providers
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Pulmonary Rehabilitation (PR) MP-037-MC-ALL Medical Management Provider Notice Date: 11/01/2017 Issue Date: 12/01/2017 Effective
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationPULMONARY REHABILITATION Current Evidence and Recommendations
PULMONARY REHABILITATION Current Evidence and Recommendations Overview Introduction to Pulmonary Rehabilitation Pathophysiolgy of Exercise Limitation Exercise training Current evidence for COPD Current
More informationDisclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:
Digging for GOLD Rebecca Young, PharmD, BCACP, Roosevelt University College of Pharmacy Assistant Professor of Clinical Sciences Practice Site Advocate Medical Group-Nesset Pavilion Disclosure and Conflict
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationAn estimated 3 million people are
clinical focus An exploration of self-efficacy and self-management in COPD patients Edwina Simpson and Martyn Jones Abstract Aim: This study examined if self-efficacy in managing chronic obstructive pulmonary
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationFact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)
Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Jin S. Oh, PharmD Larkin Community Hospital January 10, 2016 Fact COPD is the third leading cause of death in the United
More informationUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
Thorax 1999;54:581 586 581 Academic Department of Respiratory Medicine, St Bartholomew s and Royal London School of Medicine and Dentistry, London Chest Hospital, London, UK EAPaul R Garrod R Garnham J
More informationLessons to be learned from cardiopulmonary rehabilitation
REHABILITATION AFTER CRITICAL ILLNESS: Lessons to be learned from cardiopulmonary rehabilitation Rik Gosselink, PT, PhD, FERS Faculty of Kinesiology and Rehabilitation Sciences University Hospitals Leuven,
More informationBode index as a predictor of severity in patients with chronic obstructive pulmonary disease.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 5 Ver. VII (May. 2016), PP 93-100 www.iosrjournals.org Bode index as a predictor of severity
More informationA comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma
Eur Respir J 1999; 1: 591±596 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 93-1936 A comparison of global questions versus health status questionnaires
More informationLUNGS IN ACTION: Maintaining Exercise Capacity in Clients with COPD Post Completion of Pulmonary Rehabilitation
LUNGS IN ACTION: Maintaining Exercise Capacity in Clients with COPD Post Completion of Pulmonary Rehabilitation Heather Allan Director, COPD National Program The Australian Lung Foundation Objectives Outline
More informationDivision of Pulmonary, Critical Care, and Sleep Medicine, Jacksonville, FL. Department of Internal Medicine, Wichita, KS
in Patients with Respiratory Disease Furqan Shoaib Siddiqi, M.D. 1, Said Chaaban, M.D. 2, Erin Petersen, M.S.N., A.P.R.N. 3, K James Kallail, Ph.D. 2, Mary Hope, B.H.S., A.R.T., R.R.T., C.P.F.T. 3, Daniel
More informationThe Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference
1 NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK 2 Harefield Pulmonary Rehabilitation Unit, Royal Brompton & Harefield NHS
More informationThe impacts of cognitive impairment on acute exacerbations of chronic obstructive pulmonary disease
The impacts of cognitive impairment on acute exacerbations of chronic obstructive pulmonary disease Dr. Lo Iek Long Department of Respiratory Medicine C.H.C.S.J. Chronic Obstructive Pulmonary Disease (COPD)
More informationFatigue in COPD. Dr. Jan Vercoulen, Clinical Psychologist. Dpt. Medical Psychology Radboud University Nijmegen Medical Center
Fatigue in COPD Dr. Jan Vercoulen, Clinical Psychologist Dpt. Medical Psychology Radboud University Nijmegen Medical Center Definition COPD GOLD, 2016 Chronic Obstructive Pulmonary Disease = common preventable
More informationInterpreting thresholds for a clinically significant change in health status in asthma and COPD
Eur Respir J 2002; 19: 398 404 DOI: 10.1183/09031936.02.00063702 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2002 European Respiratory Journal ISSN 0903-1936 Interpreting thresholds for
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationUnderstanding the Basics of Spirometry It s not just about yelling blow
Understanding the Basics of Spirometry It s not just about yelling blow Carl D. Mottram, RRT RPFT FAARC Technical Director - Pulmonary Function Labs and Rehabilitation Associate Professor of Medicine -
More informationThe distribution of COPD in UK general practice using the new GOLD classification
ORIGINAL ARTICLE COPD The distribution of COPD in UK general practice using the new GOLD classification John Haughney 1, Kevin Gruffydd-Jones 2, June Roberts 3, Amanda J. Lee 4, Alison Hardwell 5 and Lorcan
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationSelf effi cacy measurement and goal attainment after pulmonary rehabilitation
ORIGINAL RESEARCH Self effi cacy measurement and goal attainment after pulmonary rehabilitation Rachel Garrod Johanna Marshall Fiona Jones School of Physiotherapy, St George s, University of London and
More informationDoes the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?
AUTHOR COPY ORIGINAL RESEARCH Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Kian-Chung Ong 1 Suat-Jin Lu 1 Cindy Seok-Chin Soh 2 1 Department
More informationAcute Exacerbations of COPD in Subjects Completing Pulmonary Rehabilitation
Acute Exacerbations of COPD in Subjects Completing Pulmonary Rehabilitation S. Jocelyn Carr, Roger S. Goldstein and Dina Brooks Chest 2007;132;127-134; Prepublished online May 2, 2007; DOI 10.1378/chest.07-0269
More informationC hronic obstructive pulmonary disease (COPD) is one of
589 RESPIRATORY INFECTIONS Time course of recovery of health status following an infective exacerbation of chronic bronchitis S Spencer, P W Jones for the GLOBE Study Group... Thorax 2003;58:589 593 See
More informationOutpatient Pulmonary Rehabilitation. Description
Subject: Outpatient Pulmonary Rehabilitation Page: 1 of 16 Last Review Status/Date: March 2015 Outpatient Pulmonary Rehabilitation Description Pulmonary rehabilitation (PR) is a multidisciplinary approach
More informationChronic Obstructive Pulmonary Disease (COPD) KAREN ALLEN MD PULMONARY & CRITICAL CARE MEDICINE VA HOSPITAL OKC / OUHSC
Chronic Obstructive Pulmonary Disease (COPD) KAREN ALLEN MD PULMONARY & CRITICAL CARE MEDICINE VA HOSPITAL OKC / OUHSC I have no financial disclosures Definition COPD is a preventable and treatable disease
More informationBenefi ts of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
ORIGINAL RESEARCH Benefi ts of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients Barakat Shahin 1 Michele Germain 2 Alzahouri Kazem 3 Guy Annat
More informationShaping a Dynamic Future in Respiratory Practice. #DFResp
Shaping a Dynamic Future in Respiratory Practice #DFResp www.dynamicfuture.co.uk Inhaled Therapy in COPD: Past, Present and Future Richard Russell Chest Physician West Hampshire Integrated Respiratory
More informationCommunity pulmonary rehabilitation: a multidisciplinary approach
Community pulmonary rehabilitation: a multidisciplinary approach Lindsay Welch Pulmonary rehabilitation is a well-evidenced programme of therapy for patients with chronic obstructive pulmonary disease
More informationTORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
More informationPhysiotherapy Program, Faculty of Allied Health Sciences Jalan Raja Muda Abdul Aziz, Kuala Lumpur 2
: 21-26 A Measure of Health-related Quality of Life (HRQoL) of COPD Patients Following Pulmonary Rehabilitation Program with Two Health Index Questionnaire (SF-36 and SGRQ) 1 R Ayiesah*, 2 S Riza & 1 ZY
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationCOPD. Helen Suen & Lexi Smith
COPD Helen Suen & Lexi Smith What is COPD? Chronic obstructive pulmonary disease: a non reversible, long term lung disease Characterized by progressively limited airflow and an inability to perform full
More informationOutpatient Pulmonary Rehabilitation
Outpatient Pulmonary Rehabilitation Policy Number: 8.03.05 Last Review: 7/2018 Origination: 7/1995 Next Review: 7/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for
More informationSupplementary Online Content
Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published
More information9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationUnderstanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationaclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A.
aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A. 05 October 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and
More informationPulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease
ORIGINAL ARTICLE Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease Virendra Singh, Dinesh Chand Khandelwal, Rakesh Khandelwal and Surendra Abusaria Pulmonary Division, Department
More informationOffice Based Spirometry
Osteopathic Family Physician (2014)1, 14-18 Scott Klosterman, DO; Woodson Crenshaw, OMS4 Spartanburg Regional Family Medicine Residency Program; Edward Via College of Osteopathic Medicine - Virginia Campus
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationARTICLE IN PRESS. Katia Foglio a, Luca Bianchi a, Gisella Bruletti b, Roberto Porta a, Michele Vitacca a, Bruno Balbi c, Nicolino Ambrosino d,
Respiratory Medicine (07) 101, 1961 1970 Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs
More informationWhat s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM
What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM Covering: Basic Definition New assessment criteria Some newer treatments BiPAP Not Covering: Definitions: Chronic Obstructive Pulmonary
More informationQuality of Life and Related Factors in Patients with Chronic Obstructive Pulmonary Disease
51 Quality of Life and Related Factors in Patients with COPD ORIGINAL RESEARCH ARTICLE Tanaffos (2006) 5(3), 51-56 2006 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Quality
More informationThe Art and Science of Pulmonary Rehab. Pam Haines, RCP Cardiopulmonary Rehab Manager
The Art and Science of Pulmonary Rehab Pam Haines, RCP Cardiopulmonary Rehab Manager ATS/ERS Statement on PR As defined by the 2013 ATS/ERS Statement on Pulmonary Rehabilitation, PR is a comprehensive
More informationEpidemiology of COPD Prof. David M. Mannino, M.D.
Epidemiology of COPD David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health College of Public Health University of Kentucky 1 Outline Definitions Severity Progression
More informationNational COPD Audit Programme
National COPD Audit Programme Planning for every breath Primary Care Audit (Wales) 2015-17 Findings and quality improvement The audit programme partnership Working in strategic partnership: Supported by:
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationAnyone who smokes and/or has shortness of breath and sputum production could have COPD
COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough
More informationOptimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease a systematic review
Original Paper Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease a systematic review Chronic Respiratory Disease 8(2) 129 140 ª The Author(s) 2011
More informationManuscript type: Research letter
TITLE PAGE Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups. Authors Currow DC, 1,2,3 Dal Grande E, 4 Ferreira D, 1 Johnson
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationCOPD: A Renewed Focus. Disclosures
COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss
More informationAsthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research
Asthma and COPD in older people lumping or splitting? Christine Jenkins Concord Hospital Woolcock Institute of Medical Research Concord Hospital Woolcock Institute of Medical Research Joe has asthma What
More informationAnti-tussivestussives
PULMONARY REHABILITATION IN COPD WHAT DO WE OFFER ROUTINELY? Treatment of exacerbation Treatment of heart failure Treatment of infection Maintainance pharmacotherapy Domicillary oxygen Help for smoking
More informationPatient Assessment Quality of Life
Patient Assessment Quality of Life STEP 1 Learning objectives This module will provide you with an understanding of the importance of assessing Quality of Life (QoL) in patients and the role that quality
More informationOccupational exposures are associated with worse morbidity in patients with COPD
Occupational exposures are associated with worse morbidity in patients with COPD Laura M Paulin 1, Gregory B Diette 1,2, Paul D Blanc 3, Nirupama Putcha 1, Mark D Eisner 4, Richard E Kanner 5, Andrew J
More informationAuthor s Accepted Manuscript
Author s Accepted Manuscript Low levels of physical activity predict worse survival to lung transplantation and poor early postoperative outcomesphysical activity level in lung transplantation James R.
More informationJOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
More informationPulmonary rehabilitation in severe COPD.
Pulmonary rehabilitation in severe COPD daniel.langer@faber.kuleuven.be Content Rehabilitation (how) does it work? How to train the ventilatory limited patient? Chronic Obstructive Pulmonary Disease NHLBI/WHO
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More information